Literature DB >> 20621008

Clinical use of misoprostol in nonpregnant women: review article.

Chainarong Choksuchat1.   

Abstract

Misoprostol, a prostaglandin E1 derivative, has been widely used in nonpregnant women because of its cervical ripening and uterotonic effects. A large number of studies have demonstrated its effectiveness in enhancing ease of cervical dilation. This review article describes its pharmacokinetic profile and the relationship between prostaglandins and cervical ripening and uterine contraction and provides a review of the clinical use of misoprostol in nonpregnant women including cervical priming before hysteroscopy, before insertion of an intrauterine device, in endometrium biopsy, preoperatively in myomectomy, and before intrauterine insemination to improve pregnancy rates. Adverse effects are also described. Copyright (c) 2010 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621008     DOI: 10.1016/j.jmig.2010.03.015

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  2 in total

1.  Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening.

Authors:  Brenda C Timmons; Jeff Reese; Simona Socrate; Noah Ehinger; Bibhash C Paria; Ginger L Milne; Meredith L Akins; Richard J Auchus; Don McIntire; Michael House; Mala Mahendroo
Journal:  Endocrinology       Date:  2013-12-20       Impact factor: 4.736

2.  Effect of vaginal misoprostol on pregnancy rate after intrauterine insemination: a randomized controlled trial.

Authors:  Ziba Zahiri Sorouri; Maryan Asgharnia; Ameneh Gholampoor
Journal:  Iran J Reprod Med       Date:  2015-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.